Literature DB >> 28954839

Young Pigs Consuming Lysozyme Transgenic Goat Milk Are Protected from Clinical Symptoms of Enterotoxigenic Escherichia coli Infection.

Lydia C Garas1, Caitlin A Cooper1, Matthew W Dawson2, Jane-Ling Wang2, James D Murray1,3, Elizabeth A Maga4.   

Abstract

Background: Diarrheal diseases in infancy and childhood are responsible for substantial morbidity and mortality in developing nations. Lysozyme, an antimicrobial component of human milk, is thought to play a role in establishing a healthy intestinal microbiota and immune system. Consumption of breast milk has been shown to prevent intestinal infections and is a recommended treatment for infants with diarrhea.Objective: This study aimed to examine the ability of lysozyme-rich goat milk to prevent intestinal infection.
Methods: Six-week-old Hampshire-Yorkshire pigs were assigned to treatment groups balanced for weight, sex, and litter and were fed milk from nontransgenic control goats (GM group) or human lysozyme transgenic goats (hLZM group) for 2 wk before they were challenged with porcine-specific enterotoxigenic Escherichia coli (ETEC). Fecal consistency, complete blood counts, intestinal histology, and microbial populations were evaluated.
Results: Pigs in the hLZM group had less severe diarrhea than did GM pigs at 24 and 48 h after ETEC infection (P = 0.01 and 0.05, respectively), indicating a less severe clinical disease state. Relative to baseline, postmilk hLZM pigs had 19.9% and 137% enrichment in fecal Bacteroidetes (P = 0.028) and Paraprevotellaceae (P = 0.003), respectively, and a 93.8% reduction in Enterobacteriaceae (P = 0.007), whereas GM pigs had a 60.9% decrease in Lactobacillales (P = 0.003) and an 83.3% enrichment in Burkholderiales (P = 0.010). After ETEC infection, hLZM pigs tended to have lower amounts (68.7% less) of fecal Enterobacteriaceae than did GM pigs (P = 0.058). There were 83.1% fewer bacteria translocated into the mesenteric lymph nodes of hLZM pigs than into those of GM pigs (P = 0.039), and hLZM pigs had 34% lower mucin 1 and 61% higher tumor necrosis factor-α expression in the ileum than did GM pigs (P = 0.046 and 0.034, respectively).
Conclusion: Results of this study indicate that human lysozyme milk consumption before and during ETEC infection has a positive effect on clinical disease, intestinal mucosa, and gut microbiota in young pigs.
© 2017 American Society for Nutrition.

Entities:  

Keywords:  E. coli infection; diarrhea; genetic engineering; lysozyme; medical model; microbiota; pigs

Mesh:

Substances:

Year:  2017        PMID: 28954839     DOI: 10.3945/jn.117.251322

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  5 in total

Review 1.  Invited review: strategic adoption of antibiotic-free pork production: the importance of a holistic approach.

Authors:  John F Patience; Alejandro Ramirez
Journal:  Transl Anim Sci       Date:  2022-05-16

2.  Lysozyme improves gut performance and protects against enterotoxigenic Escherichia coli infection in neonatal piglets.

Authors:  Guangping Huang; Xiangqing Li; Dan Lu; Shen Liu; Xun Suo; Qiuyan Li; Ning Li
Journal:  Vet Res       Date:  2018-02-20       Impact factor: 3.683

3.  Utilizing the fecal microbiota to understand foal gut transitions from birth to weaning.

Authors:  Ubaldo De La Torre; John D Henderson; Kathleen L Furtado; Madeleine Pedroja; O'Malley Elenamarie; Anthony Mora; Monica Y Pechanec; Elizabeth A Maga; Michael J Mienaltowski
Journal:  PLoS One       Date:  2019-04-30       Impact factor: 3.240

Review 4.  Enterotoxigenic Escherichia coli infection of weaned pigs: Intestinal challenges and nutritional intervention to enhance disease resistance.

Authors:  Kwangwook Kim; Minho Song; Yanhong Liu; Peng Ji
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

5.  Effects of dietary lysozyme supplementation on growth performance, nutrient digestibility, intestinal microbiota, and blood profiles of weanling pigs challenged with Escherichia coli.

Authors:  Jae Hong Park; Shanmugam Sureshkumar; In Ho Kim
Journal:  J Anim Sci Technol       Date:  2021-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.